Abstract
The interaction of hepcidin (HEPC) and ferroportin (FPN) is an essential event in iron homeostasis. HEPC binds to FPN, and subsequently degrades it through phosphorylation and ubiquitination. Present work described a computational study to identify interfacial residues involved in FPN–HEPC interactions. We have predicted three-dimensional structure of human FPN using homology modeling followed by docking analysis and molecular dynamics simulations. Our study revealed that FPN has HEPC-binding sites on extracellular loops: ECL4, ECL5 and ECL6. The provided outcome is consistent with mutagenesis studies on FPN. We have identified several electrostatic interactions between charged residues Asp325 (ECL4), ECL5 (Glu448) and Glu518 (ECL6) of FPN with residues His3, Arg16, Lys18 of HEPC, which are essentially important for interfacial contact between them. These results provide an evidence for structural basis of FPN–HEPC interactions and their future clinical application.
Keywords: Ferroportin, Hepcidin, Structural modulation, Elastic network model, Iron homeostasis.
Letters in Drug Design & Discovery
Title:Identification of Interfacial Residues Involved in Hepcidin-Ferroportin Interaction
Volume: 11 Issue: 3
Author(s): Prasoon Kumar Thakur, Amresh Prakash, Parvez Khan, Robert E. Fleming, Abdul Waheed, Faizan Ahmad and Md. Imtaiyaz Hassan
Affiliation:
Keywords: Ferroportin, Hepcidin, Structural modulation, Elastic network model, Iron homeostasis.
Abstract: The interaction of hepcidin (HEPC) and ferroportin (FPN) is an essential event in iron homeostasis. HEPC binds to FPN, and subsequently degrades it through phosphorylation and ubiquitination. Present work described a computational study to identify interfacial residues involved in FPN–HEPC interactions. We have predicted three-dimensional structure of human FPN using homology modeling followed by docking analysis and molecular dynamics simulations. Our study revealed that FPN has HEPC-binding sites on extracellular loops: ECL4, ECL5 and ECL6. The provided outcome is consistent with mutagenesis studies on FPN. We have identified several electrostatic interactions between charged residues Asp325 (ECL4), ECL5 (Glu448) and Glu518 (ECL6) of FPN with residues His3, Arg16, Lys18 of HEPC, which are essentially important for interfacial contact between them. These results provide an evidence for structural basis of FPN–HEPC interactions and their future clinical application.
Export Options
About this article
Cite this article as:
Thakur Kumar Prasoon, Prakash Amresh, Khan Parvez, Fleming E. Robert, Waheed Abdul, Ahmad Faizan and Hassan Imtaiyaz Md., Identification of Interfacial Residues Involved in Hepcidin-Ferroportin Interaction, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/15701808113106660088
DOI https://dx.doi.org/10.2174/15701808113106660088 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lentiviral Delivery of RNAi Effectors Against HIV-1
Current Topics in Medicinal Chemistry Identification of Expressed miRNAs in Human Rheumatoid Arthritis Using Computational Approach – Discovery of a New miR-7167 from Human
MicroRNA Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?
CNS & Neurological Disorders - Drug Targets n-3 Polyunsaturated Fatty Acids as Signal Transduction Modulators and Therapeutical Agents in Cancer
Current Signal Transduction Therapy Atrial Fibrillation: Biomarkers Determining Prognosis
Current Medicinal Chemistry Why Is Homocysteine Toxic for the Nervous and Immune Systems?
Current Aging Science Levocetirizine: An Update
Current Medicinal Chemistry Cyclooxygenase-1 and -2 in the Different Stages of Alzheimers Disease Pathology
Current Pharmaceutical Design Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine BACE1: Expression, Regulation, and Therapeutic Potential of the Major Alzheimer’s Disease Beta-Secretase
Current Enzyme Inhibition Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry Innovations in Drug Delivery for Chronic Wound Healing
Current Pharmaceutical Design Importance of Snake Venom Metalloproteinases in Cell Biology: Effects on Platelets,Inflammatory and Endothelial Cells
Current Pharmaceutical Design Long-circulating Targeted Nanoparticles for Cancer Therapy
Current Nanoscience Heme Oxygenase-1 and Iron in Liver Inflammation: A Complex Alliance
Current Drug Targets Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
Current Alzheimer Research Hemichannels in Cerebral Ischemia
Current Molecular Medicine Prediction of Citrullination Sites on the Basis of mRMR Method and SNN
Combinatorial Chemistry & High Throughput Screening Foreword from the Editor
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Dexamethasone Use During Pregnancy: Potential Adverse Effects on Embryonic Skeletogenesis
Current Pharmaceutical Design